{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:33:46Z","timestamp":1791862426744,"version":"4.3.4"},"reference-count":162,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001108","name":"Ophthalmic Research Institute of Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropeptides"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.npep.2025.102583","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T16:33:39Z","timestamp":1766594019000},"page":"102583","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Neuropeptide Y at the crossroads of neurodegeneration: Mechanistic insights and emerging therapeutic strategies"],"prefix":"10.1016","volume":"115","author":[{"given":"Viswanthram","family":"Palanivel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akanksha","family":"Salkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avinash","family":"Shenoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taslima Akter","family":"Eva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rumandee","family":"Perera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Chitranshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veer","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyi","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Mirzaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart L.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devaraj","family":"Basavarajappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.npep.2025.102583_bb0005","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0014-5793(90)80069-U","article-title":"Y1 receptors for neuropeptide Y are coupled to mobilization of intracellular calcium and inhibition of adenylate cyclase","volume":"260","author":"Aakerlund","year":"1990","journal-title":"FEBS Lett."},{"issue":"6","key":"10.1016\/j.npep.2025.102583_bb0010","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1634\/stemcells.2008-0056","article-title":"Neuropeptide Y promotes neurogenesis in murine subventricular zone","volume":"26","author":"Agasse","year":"2008","journal-title":"Stem Cells"},{"issue":"3","key":"10.1016\/j.npep.2025.102583_bb0015","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/acn3.721","article-title":"Eating peptides: biomarkers of neurodegeneration in amyotrophic lateral sclerosis and frontotemporal dementia","volume":"6","author":"Ahmed","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"4","key":"10.1016\/j.npep.2025.102583_bb0020","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000117347","article-title":"Cerebrospinal fluid neuropeptide Y in Alzheimer\u2019s disease","volume":"30","author":"Alom","year":"1990","journal-title":"Eur. Neurol."},{"issue":"5","key":"10.1016\/j.npep.2025.102583_bb0025","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.neuint.2007.01.010","article-title":"NPY in rat retina is present in neurons, in endothelial cells and also in microglial and M\u00fcller cells","volume":"50","author":"Alvaro","year":"2007","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.npep.2025.102583_bb0030","doi-asserted-by":"crossref","unstructured":"Alvaro, A.R., et al., Neuropeptide Y stimulates retinal neural cell proliferation--involvement of nitric oxide. J. Neurochem., 2008. 105(6): p. 2501\u201310.","DOI":"10.1111\/j.1471-4159.2008.05334.x"},{"issue":"5","key":"10.1016\/j.npep.2025.102583_bb0035","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1111\/j.1471-4159.2009.06079.x","article-title":"Neuropeptide Y inhibits [Ca2+] i changes in rat retinal neurons through NPY Y1, Y4, and Y5 receptors","volume":"109","author":"Alvaro","year":"2009","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.npep.2025.102583_bb0040","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.pharmthera.2004.11.002","article-title":"Calmodulin kinase signaling in heart: an intriguing candidate target for therapy of myocardial dysfunction and arrhythmias","volume":"106","author":"Anderson","year":"2005","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.npep.2025.102583_bb0045","first-page":"159","article-title":"Diabetic retinopathy: an overview on mechanisms","volume":"3","author":"Ansari","year":"2022","journal-title":"Pathophysiol. Pharmacother. Diabetol."},{"issue":"6","key":"10.1016\/j.npep.2025.102583_bb0050","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and treatment of Parkinson disease: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.npep.2025.102583_bb0055","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1001\/archneur.1988.00520270043019","article-title":"Cerebrospinal fluid somatostatin and neuropeptide Y. Concentrations in aging and in dementia of the Alzheimer type with and without extrapyramidal signs","volume":"45","author":"Atack","year":"1988","journal-title":"Arch. Neurol."},{"issue":"11","key":"10.1016\/j.npep.2025.102583_bb0060","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/jnen\/nlae054","article-title":"Alterations to metabolic hormones in amyotrophic lateral sclerosis and frontotemporal dementia postmortem human tissue","volume":"83","author":"Atkinson","year":"2024","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"8","key":"10.1016\/j.npep.2025.102583_bb0065","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1080\/15548627.2015.1062202","article-title":"NPY\/neuropeptide Y enhances autophagy in the hypothalamus: a mechanism to delay aging?","volume":"11","author":"Aveleira","year":"2015","journal-title":"Autophagy"},{"issue":"13","key":"10.1016\/j.npep.2025.102583_bb0070","doi-asserted-by":"crossref","first-page":"E1642","DOI":"10.1073\/pnas.1416609112","article-title":"Neuropeptide Y stimulates autophagy in hypothalamic neurons","volume":"112","author":"Aveleira","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.npep.2025.102583_bb0075","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1016\/j.neuropharm.2012.02.015","article-title":"Neuropeptide Y promotes neurogenesis and protection against methamphetamine-induced toxicity in mouse dentate gyrus-derived neurosphere cultures","volume":"62","author":"Baptista","year":"2012","journal-title":"Neuropharmacology"},{"issue":"1\u20132","key":"10.1016\/j.npep.2025.102583_bb0080","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0006-8993(01)02141-2","article-title":"Interleukin-1beta induces expression of neuropeptide Y in primary astrocyte cultures in a cytokine-specific manner: induction in human but not rat astrocytes","volume":"896","author":"Barnea","year":"2001","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.npep.2025.102583_bb0085","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/ana.410200303","article-title":"Neuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer\u2019s disease","volume":"20","author":"Beal","year":"1986","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.npep.2025.102583_bb0090","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/bip.360370207","article-title":"Structure-activity relationships of neuropeptide Y analogues with respect to Y1 and Y2 receptors","volume":"37","author":"Beck-Sickinger","year":"1995","journal-title":"Biopolymers"},{"issue":"5","key":"10.1016\/j.npep.2025.102583_bb0095","first-page":"R1030","article-title":"Acute food deprivation and chronic food restriction differentially affect hypothalamic NPY mRNA expression","volume":"285","author":"Bi","year":"2003","journal-title":"Am. J. Phys. Regul. Integr. Comp. Phys."},{"issue":"5","key":"10.1016\/j.npep.2025.102583_bb0100","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1159\/000125626","article-title":"Altered expression of hypothalamic neuropeptide mRNAs in food-restricted and food-deprived rats","volume":"52","author":"Brady","year":"1990","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.npep.2025.102583_bb0105","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jtos.2024.08.011","article-title":"Tear neuropeptide Y as a non-invasive marker of peripheral microvascular complications in type 1 diabetes","volume":"34","author":"Britten-Jones","year":"2024","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.npep.2025.102583_bb0110","doi-asserted-by":"crossref","first-page":"6501031","DOI":"10.1155\/2018\/6501031","article-title":"Mechanisms of endogenous neuroprotective effects of astrocytes in brain injury","volume":"2018","author":"Bylicky","year":"2018","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"3\u20134","key":"10.1016\/j.npep.2025.102583_bb0115","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0891-0618(00)00107-1","article-title":"Characterization of NPY mRNA-expressing cells in the human brain: co-localization with Y2 but not Y1 mRNA in the cerebral cortex, hippocampus, amygdala, and striatum","volume":"20","author":"Caberlotto","year":"2000","journal-title":"J. Chem. Neuroanat."},{"issue":"3","key":"10.1016\/j.npep.2025.102583_bb0120","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/(SICI)1099-1387(200003)6:3<97::AID-PSC236>3.0.CO;2-E","article-title":"Molecular characterization of the ligand-receptor interaction of the neuropeptide Y family","volume":"6","author":"Cabrele","year":"2000","journal-title":"J. Pept. Sci."},{"issue":"2","key":"10.1016\/j.npep.2025.102583_bb0125","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0169-328X(02)00555-7","article-title":"Increased neuropeptide Y mRNA expression in striatum in Parkinson\u2019s disease","volume":"110","author":"Cannizzaro","year":"2003","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"6","key":"10.1016\/j.npep.2025.102583_bb0130","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's disease collaborative research group","volume":"72","year":"1993","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.npep.2025.102583_bb0135","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/cne.902480307","article-title":"Distribution of altered hippocampal neurons and axons immunoreactive with antisera against neuropeptide Y in Alzheimer\u2019s-type dementia","volume":"248","author":"Chan-Palay","year":"1986","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.npep.2025.102583_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2018.00493","article-title":"Neuropeptides exert neuroprotective effects in Alzheimer's disease","volume":"11","author":"Chen","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.npep.2025.102583_bb0145","doi-asserted-by":"crossref","DOI":"10.1177\/20406223211041936","article-title":"Neuropeptide Y: a potential theranostic biomarker for diabetic peripheral neuropathy in patients with type-2 diabetes","volume":"12","author":"Cho","year":"2021","journal-title":"Ther Adv Chronic Dis"},{"issue":"8","key":"10.1016\/j.npep.2025.102583_bb0150","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/aos.13806","article-title":"Neuropeptide Y treatment induces retinal vasoconstriction and causes functional and histological retinal damage in a porcine ischaemia model","volume":"96","author":"Christiansen","year":"2018","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.npep.2025.102583_bb0155","doi-asserted-by":"crossref","first-page":"44461","DOI":"10.1038\/srep44461","article-title":"Calretinin and neuropeptide Y interneurons are differentially altered in the motor cortex of the SOD1(G93A) mouse model of ALS","volume":"7","author":"Clark","year":"2017","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.npep.2025.102583_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci11080969","article-title":"Differential NPY-Y1 receptor density in the motor cortex of ALS patients and familial model of ALS","volume":"11","author":"Clark","year":"2021","journal-title":"Brain Sci."},{"issue":"3","key":"10.1016\/j.npep.2025.102583_bb0165","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/jnc.15125","article-title":"Pathogenic or protective? Neuropeptide Y in amyotrophic lateral sclerosis","volume":"156","author":"Clark","year":"2021","journal-title":"J. Neurochem."},{"issue":"11","key":"10.1016\/j.npep.2025.102583_bb0170","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1002\/acn3.51885","article-title":"Intranasal neuropeptide Y1 receptor antagonism improves motor deficits in symptomatic SOD1 ALS mice","volume":"10","author":"Clark","year":"2023","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"4","key":"10.1016\/j.npep.2025.102583_bb0175","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1021\/cn200127e","article-title":"Neuropeptide Y protects rat cortical neurons against beta-amyloid toxicity and re-establishes synthesis and release of nerve growth factor","volume":"3","author":"Croce","year":"2012","journal-title":"ACS Chem. Neurosci."},{"issue":"1\u20132","key":"10.1016\/j.npep.2025.102583_bb0180","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11010-013-1567-0","article-title":"NPY modulates miR-30a-5p and BDNF in opposite direction in an in vitro model of Alzheimer disease: a possible role in neuroprotection?","volume":"376","author":"Croce","year":"2013","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.npep.2025.102583_bb0185","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3389\/fendo.2018.00283","article-title":"Hypothalamic mitochondrial dysfunction as a target in obesity and metabolic disease","volume":"9","author":"Cunarro","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"10.1016\/j.npep.2025.102583_bb0190","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jchemneu.2005.05.001","article-title":"A histochemical and immunohistochemical analysis of the subependymal layer in the normal and Huntington's disease brain","volume":"30","author":"Curtis","year":"2005","journal-title":"J. Chem. Neuroanat."},{"issue":"9","key":"10.1016\/j.npep.2025.102583_bb0195","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nrn2216","article-title":"The effect of neurodegenerative diseases on the subventricular zone","volume":"8","author":"Curtis","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"issue":"4","key":"10.1016\/j.npep.2025.102583_bb0200","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.neuroscience.2003.10.041","article-title":"Y2 receptor expression and inhibition of voltage-dependent Ca2+ influx into rod bipolar cell terminals","volume":"125","author":"D\u2019Angelo","year":"2004","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.npep.2025.102583_bb0205","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0022-510X(90)90057-T","article-title":"A quantitative assessment of somatostatin-like and neuropeptide Y-like immunostained cells in the frontal and temporal cortex of patients with Alzheimer's disease","volume":"96","author":"Davies","year":"1990","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.npep.2025.102583_bb0210","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0006-8993(85)90921-7","article-title":"Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington\u2019s disease","volume":"340","author":"Dawbarn","year":"1985","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.npep.2025.102583_bb0215","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.expneurol.2012.09.004","article-title":"Neuropeptide Y and its role in CNS disease and repair","volume":"238","author":"Decressac","year":"2012","journal-title":"Exp. Neurol."},{"issue":"3","key":"10.1016\/j.npep.2025.102583_bb0220","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.nbd.2009.02.017","article-title":"Neuropeptide Y stimulates proliferation, migration and differentiation of neural precursors from the subventricular zone in adult mice","volume":"34","author":"Decressac","year":"2009","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.npep.2025.102583_bb0225","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.expneurol.2010.07.022","article-title":"Neuropeptide Y modifies the disease course in the R6\/2 transgenic model of Huntington's disease","volume":"226","author":"Decressac","year":"2010","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.npep.2025.102583_bb0230","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer's disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol. Neurodegener."},{"issue":"2","key":"10.1016\/j.npep.2025.102583_bb0235","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0306-4522(00)00261-X","article-title":"Neuropeptides in hippocampus and cortex in transgenic mice overexpressing V717F beta-amyloid precursor protein--initial observations","volume":"100","author":"Diez","year":"2000","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.npep.2025.102583_bb0240","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.nbd.2003.08.003","article-title":"Neuropeptide alterations in the hippocampal formation and cortex of transgenic mice overexpressing beta-amyloid precursor protein (APP) with the Swedish double mutation (APP23)","volume":"14","author":"Diez","year":"2003","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.npep.2025.102583_bb0245","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bbr.2013.01.039","article-title":"Neuropeptide Y (NPY) prevents depressive-like behavior, spatial memory deficits and oxidative stress following amyloid-beta (Abeta(1-40)) administration in mice","volume":"244","author":"dos Santos","year":"2013","journal-title":"Behav. Brain Res."},{"issue":"19","key":"10.1016\/j.npep.2025.102583_bb0250","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1093\/hmg\/ddv271","article-title":"Neuropeptide Y mitigates neuropathology and motor deficits in mouse models of Machado-Joseph disease","volume":"24","author":"Duarte-Neves","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.npep.2025.102583_bb0255","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.nbd.2016.07.022","article-title":"Neuropeptide Y (NPY) as a therapeutic target for neurodegenerative diseases","volume":"95","author":"Duarte-Neves","year":"2016","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.npep.2025.102583_bb0260","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1038\/s41598-021-82339-5","article-title":"Neuropeptide Y (NPY) intranasal delivery alleviates Machado-Joseph disease","volume":"11","author":"Duarte-Neves","year":"2021","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.npep.2025.102583_bb0265","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028035","article-title":"Pathology of neurodegenerative diseases","volume":"9","author":"Dugger","year":"2017","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"4","key":"10.1016\/j.npep.2025.102583_bb0270","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a033118","article-title":"Clinical neurology and epidemiology of the major neurodegenerative diseases","volume":"10","author":"Erkkinen","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.npep.2025.102583_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.npep.2022.102232","article-title":"Kinetics of neuropeptide Y, catecholamines, and physiological responses during moderate and heavy intensity exercises","volume":"92","author":"Eugster","year":"2022","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2025.102583_bb0280","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.expneurol.2018.01.001","article-title":"Activation of NPY-Y2 receptors ameliorates disease pathology in the R6\/2 mouse and PC12 cell models of Huntington's disease","volume":"302","author":"Fatoba","year":"2018","journal-title":"Exp. Neurol."},{"issue":"53","key":"10.1016\/j.npep.2025.102583_bb0285","doi-asserted-by":"crossref","first-page":"41921","DOI":"10.1074\/jbc.M110.164020","article-title":"Neuropeptide Y modulation of interleukin-1beta (IL-1beta)-induced nitric oxide production in microglia","volume":"285","author":"Ferreira","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.npep.2025.102583_bb0290","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/1742-2094-8-169","article-title":"Neuropeptide Y inhibits interleukin-1beta-induced phagocytosis by microglial cells","volume":"8","author":"Ferreira","year":"2011","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.npep.2025.102583_bb0295","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1471-4159.2011.07541.x","article-title":"Neuropeptide Y inhibits interleukin-1 beta-induced microglia motility","volume":"120","author":"Ferreira","year":"2012","journal-title":"J. Neurochem."},{"issue":"7","key":"10.1016\/j.npep.2025.102583_bb0300","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.18632\/aging.100996","article-title":"Caloric restriction stimulates autophagy in rat cortical neurons through neuropeptide Y and ghrelin receptors activation","volume":"8","author":"Ferreira-Marques","year":"2016","journal-title":"Aging (Albany NY)"},{"issue":"2","key":"10.1016\/j.npep.2025.102583_bb0305","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1152\/physrev.00011.2017","article-title":"Neuronal cell death","volume":"98","author":"Fricker","year":"2018","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.npep.2025.102583_bb0310","article-title":"Cellular stress responses: cell survival and cell death","volume":"2010","author":"Fulda","year":"2010","journal-title":"Int. J. Cell Biol."},{"key":"10.1016\/j.npep.2025.102583_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102357","article-title":"Neurodegenerative disorders: mechanisms of degeneration and therapeutic approaches with their clinical relevance","volume":"99","author":"Gadhave","year":"2024","journal-title":"Ageing Res. Rev."},{"issue":"9","key":"10.1016\/j.npep.2025.102583_bb0320","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1111\/j.1460-9568.2012.08232.x","article-title":"Protective role of neuropeptide Y Y(2) receptors in cell death and microglial response following methamphetamine injury","volume":"36","author":"Goncalves","year":"2012","journal-title":"Eur. J. Neurosci."},{"issue":"Pt 5","key":"10.1016\/j.npep.2025.102583_bb0325","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/brain\/awt084","article-title":"Defects in the striatal neuropeptide Y system in X-linked dystonia-parkinsonism","volume":"136","author":"Goto","year":"2013","journal-title":"Brain"},{"issue":"1\u20132","key":"10.1016\/j.npep.2025.102583_bb0330","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0169-328X(03)00093-7","article-title":"Fasting activates neuropeptide Y neurons in the arcuate nucleus and the paraventricular nucleus in the rhesus macaque","volume":"113","author":"Grove","year":"2003","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"6831","key":"10.1016\/j.npep.2025.102583_bb0335","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/35073601","article-title":"Neuropeptide Y functions as a neuroproliferative factor","volume":"410","author":"Hansel","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.npep.2025.102583_bb0340","doi-asserted-by":"crossref","first-page":"17071","DOI":"10.1038\/nrdp.2017.71","article-title":"Amyotrophic lateral sclerosis","volume":"3","author":"Hardiman","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"8","key":"10.1016\/j.npep.2025.102583_bb0345","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nrneurol.2017.99","article-title":"ER stress and the unfolded protein response in neurodegeneration","volume":"13","author":"Hetz","year":"2017","journal-title":"Nat. Rev. Neurol."},{"issue":"5","key":"10.1016\/j.npep.2025.102583_bb0350","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s10571-011-9793-z","article-title":"NPY and stress 30 years later: the peripheral view","volume":"32","author":"Hirsch","year":"2012","journal-title":"Cell. Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.npep.2025.102583_bb0355","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0167-0115(96)00073-0","article-title":"Structure-affinity studies of C-terminally modified analogs of neuropeptide Y led to a novel class of peptidic Y1 receptor antagonist","volume":"65","author":"Hoffmann","year":"1996","journal-title":"Regul. Pept."},{"issue":"3","key":"10.1016\/j.npep.2025.102583_bb0360","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1515\/hsz-2018-0364","article-title":"Chemical modification of neuropeptide Y for human Y1 receptor targeting in health and disease","volume":"400","author":"Hofmann","year":"2019","journal-title":"Biol. Chem."},{"key":"10.1016\/j.npep.2025.102583_bb0365","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.neuropharm.2018.09.018","article-title":"Hippocampal NPY Y2 receptors modulate memory depending on emotional valence and time","volume":"143","author":"H\u00f6rmer","year":"2018","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.npep.2025.102583_bb0370","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.npep.2010.08.001","article-title":"Plasma neuropeptide Y levels differ in distinct diabetic conditions","volume":"44","author":"Ilhan","year":"2010","journal-title":"Neuropeptides"},{"issue":"11","key":"10.1016\/j.npep.2025.102583_bb0375","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.2174\/092986730611220401164224","article-title":"Molecular characterization of the ligand-receptor interaction of neuropeptide Y","volume":"6","author":"Ingenhoven","year":"1999","journal-title":"Curr. Med. Chem."},{"issue":"27","key":"10.1016\/j.npep.2025.102583_bb0380","doi-asserted-by":"crossref","first-page":"9096","DOI":"10.1523\/JNEUROSCI.0872-14.2014","article-title":"Transgenic mice overexpressing amyloid precursor protein exhibit early metabolic deficits and a pathologically low leptin state associated with hypothalamic dysfunction in arcuate neuropeptide Y neurons","volume":"34","author":"Ishii","year":"2014","journal-title":"J. Neurosci."},{"issue":"04","key":"10.1016\/j.npep.2025.102583_bb0385","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1055\/s-2006-924079","article-title":"The Leu7Pro polymorphism of neuropeptide Y is associated with younger age of onset of type 2 diabetes mellitus and increased risk for nephropathy in subjects with diabetic retinopathy","volume":"114","author":"Jaakkola","year":"2006","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"2","key":"10.1016\/j.npep.2025.102583_bb0390","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1600-0420.2006.00787.x","article-title":"Leucine 7-proline 7 polymorphism in the signal peptide of neuropeptide Y is not a risk factor for exudative age-related macular degeneration","volume":"85","author":"Kaarniranta","year":"2007","journal-title":"Acta Ophthalmol. Scand."},{"issue":"1","key":"10.1016\/j.npep.2025.102583_bb0395","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/0304-3940(86)90174-6","article-title":"Striatal neuropeptide Y neurones are under the influence of the nigrostriatal dopaminergic pathway: immunohistochemical evidence","volume":"66","author":"Kerkerian","year":"1986","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.npep.2025.102583_bb0400","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/0306-4522(88)90101-7","article-title":"Pharmacological characterization of dopaminergic influence on expression of neuropeptide Y immunoreactivity by rat striatal neurons","volume":"26","author":"Kerkerian","year":"1988","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.npep.2025.102583_bb0405","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ncb2152","article-title":"AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1","volume":"13","author":"Kim","year":"2011","journal-title":"Nat. Cell Biol."},{"issue":"9","key":"10.1016\/j.npep.2025.102583_bb0410","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.3390\/ijms17091584","article-title":"Neuroprotection, growth factors and BDNF-TrkB Signalling in retinal degeneration","volume":"17","author":"Kimura","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.npep.2025.102583_bb0415","doi-asserted-by":"crossref","first-page":"242","DOI":"10.17305\/bjbms.2013.2332","article-title":"Effects of single-dose neuropeptide Y on levels of hippocampal BDNF, MDA, GSH, and NO in a rat model of pentylenetetrazole-induced epileptic seizure","volume":"13","author":"Kir","year":"2013","journal-title":"Bosn. J. Basic Med. Sci."},{"issue":"2","key":"10.1016\/j.npep.2025.102583_bb0420","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0304-3940(95)11973-Z","article-title":"Plasma neuropeptide Y is reduced in patients with Alzheimer\u2019s disease","volume":"198","author":"Koide","year":"1995","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.npep.2025.102583_bb0425","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1080\/07853890410031236","article-title":"Neuropeptide Y and Y2-receptor are involved in development of diabetic retinopathy and retinal neovascularization","volume":"36","author":"Koulu","year":"2004","journal-title":"Ann. Med."},{"issue":"9","key":"10.1016\/j.npep.2025.102583_bb0430","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076497","article-title":"Modifications of hippocampal circuits and early disruption of adult neurogenesis in the tg2576 mouse model of Alzheimer's disease","volume":"8","author":"Krezymon","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.npep.2025.102583_bb0435","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","article-title":"Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes","volume":"9","author":"Kwon","year":"2020","journal-title":"Transl. Neurodegen."},{"issue":"32","key":"10.1016\/j.npep.2025.102583_bb0440","doi-asserted-by":"crossref","first-page":"13469","DOI":"10.1073\/pnas.0906678106","article-title":"Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: implications for glaucoma","volume":"106","author":"Lambiase","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.npep.2025.102583_bb0445","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","volume":"23","year":"2024","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.npep.2025.102583_bb0450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0167-0115(95)00169-7","article-title":"Evolution of neuropeptide Y, peptide YY and pancreatic polypeptide","volume":"62","author":"Larhammar","year":"1996","journal-title":"Regul. Pept."},{"issue":"3","key":"10.1016\/j.npep.2025.102583_bb0455","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0167-0115(96)00110-3","article-title":"Structural diversity of receptors for neuropeptide Y, peptide YY and pancreatic polypeptide","volume":"65","author":"Larhammar","year":"1996","journal-title":"Regul. Pept."},{"issue":"7","key":"10.1016\/j.npep.2025.102583_bb0460","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.cellsig.2015.03.016","article-title":"Neuropeptide Y receptor mediates activation of ERK1\/2 via transactivation of the IGF receptor","volume":"27","author":"Lecat","year":"2015","journal-title":"Cell. Signal."},{"key":"10.1016\/j.npep.2025.102583_bb0465","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.nbd.2015.11.014","article-title":"Translational approach for gene therapy in epilepsy: model system and unilateral overexpression of neuropeptide Y and Y2 receptors","volume":"86","author":"Ledri","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.npep.2025.102583_bb0470","doi-asserted-by":"crossref","first-page":"39340","DOI":"10.1038\/srep39340","article-title":"Agouti related peptide secreted via human mesenchymal stem cells upregulates proteasome activity in an Alzheimer's disease model","volume":"7","author":"Lee","year":"2017","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.npep.2025.102583_bb0475","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ejcb.2018.04.003","article-title":"Neuropeptide Y mitigates ER stress-induced neuronal cell death by activating the PI3K-XBP1 pathway","volume":"97","author":"Lee","year":"2018","journal-title":"Eur. J. Cell Biol."},{"issue":"6","key":"10.1016\/j.npep.2025.102583_bb0480","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1073\/pnas.96.6.3239","article-title":"Calcium\/calmodulin-dependent protein kinase II is associated with the N-methyl-D-aspartate receptor","volume":"96","author":"Leonard","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.npep.2025.102583_bb0485","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3389\/fnins.2015.00469","article-title":"Chronic glutamate toxicity in neurodegenerative diseases-what is the evidence?","volume":"9","author":"Lewerenz","year":"2015","journal-title":"Front. Neurosci."},{"issue":"9","key":"10.1016\/j.npep.2025.102583_bb0490","doi-asserted-by":"crossref","first-page":"959","DOI":"10.4103\/1673-5374.133140","article-title":"Neuropeptide Y protects cerebral cortical neurons by regulating microglial immune function","volume":"9","author":"Li","year":"2014","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.npep.2025.102583_bb0495","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3389\/fnins.2019.00869","article-title":"Roles of neuropeptide Y in neurodegenerative and Neuroimmune diseases","volume":"13","author":"Li","year":"2019","journal-title":"Front. Neurosci."},{"issue":"9","key":"10.1016\/j.npep.2025.102583_bb0500","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41419-020-02998-6","article-title":"PI3K\/AKT pathway as a key link modulates the multidrug resistance of cancers","volume":"11","author":"Liu","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.npep.2025.102583_bb0505","first-page":"327","article-title":"Phenotypic alterations in hippocampal NPY- and PV-expressing interneurons in a Presymptomatic transgenic mouse model of Alzheimer's disease","volume":"8","author":"Mahar","year":"2016","journal-title":"Front. Aging Neurosci."},{"issue":"2","key":"10.1016\/j.npep.2025.102583_bb0510","doi-asserted-by":"crossref","DOI":"10.3390\/cells10020370","article-title":"Endogenous mechanisms of neuroprotection: to boost or not to boost","volume":"10","author":"Marmolejo-Mart\u00ednez-Artesero","year":"2021","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.npep.2025.102583_bb0515","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF02260903","article-title":"Cerebrospinal fluid norepinephrine, 3-methoxy-4-hydroxyphenylglycol and neuropeptide Y levels in Parkinson's disease, multiple system atrophy and dementia of the Alzheimer type","volume":"4","author":"Martignoni","year":"1992","journal-title":"J. Neural Transm. Park. Dis. Dement. Sect."},{"issue":"4","key":"10.1016\/j.npep.2025.102583_bb0520","doi-asserted-by":"crossref","DOI":"10.1177\/1759091415598292","article-title":"Activation of neuropeptide Y receptors modulates retinal ganglion cell physiology and exerts neuroprotective actions in vitro","volume":"7","author":"Martins","year":"2015","journal-title":"ASN Neuro"},{"issue":"4","key":"10.1016\/j.npep.2025.102583_bb0525","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1523\/JNEUROSCI.16-04-01422.1996","article-title":"Neuropeptide Y1 receptors inhibit N-type calcium currents and reduce transient calcium increases in rat dentate granule cells","volume":"16","author":"McQuiston","year":"1996","journal-title":"J. Neurosci."},{"issue":"9","key":"10.1016\/j.npep.2025.102583_bb0530","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/ncb2329","article-title":"The AMPK signalling pathway coordinates cell growth, autophagy and metabolism","volume":"13","author":"Mihaylova","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.npep.2025.102583_bb0535","first-page":"57","article-title":"Neuropeptide levels in Alzheimer's disease and dementia with frontotemporal degeneration","volume":"30","author":"Minthon","year":"1990","journal-title":"J. Neural Transm. Suppl."},{"issue":"7","key":"10.1016\/j.npep.2025.102583_bb0540","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1038\/npp.2013.33","article-title":"NPY Y1 receptors differentially modulate GABAA and NMDA receptors via divergent signal-transduction pathways to reduce excitability of amygdala neurons","volume":"38","author":"Molosh","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.npep.2025.102583_bb0545","doi-asserted-by":"crossref","DOI":"10.1007\/BF00228141","article-title":"Solution structure of human neuropeptide Y","volume":"8","author":"Monks","year":"1996","journal-title":"J. Biomol. NMR"},{"issue":"6 Pt 1","key":"10.1016\/j.npep.2025.102583_bb0550","first-page":"E880","article-title":"Neuropeptide Y mobilizes Ca2+ and inhibits adenylate cyclase in human erythroleukemia cells","volume":"255","author":"Motulsky","year":"1988","journal-title":"Am. J. Phys."},{"issue":"Pt 6","key":"10.1016\/j.npep.2025.102583_bb0555","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1093\/brain\/awn079","article-title":"Neuropeptide Y gene therapy decreases chronic spontaneous seizures in a rat model of temporal lobe epilepsy","volume":"131","author":"Noe","year":"2008","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.npep.2025.102583_bb0560","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/gt.2010.23","article-title":"Anticonvulsant effects and behavioural outcomes of rAAV serotype 1 vector-mediated neuropeptide Y overexpression in rat hippocampus","volume":"17","author":"Noe","year":"2010","journal-title":"Gene Ther."},{"issue":"12","key":"10.1016\/j.npep.2025.102583_bb0565","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00702-003-0047-1","article-title":"Increased striatal neuropeptide Y immunoreactivity and its modulation by deprenyl, clonidine and L-dopa in MPTP-treated mice","volume":"110","author":"Obuchowicz","year":"2003","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"11","key":"10.1016\/j.npep.2025.102583_bb0570","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1080\/15548627.2016.1215382","article-title":"Hypothalamic AMPK-induced autophagy increases food intake by regulating NPY and POMC expression","volume":"12","author":"Oh","year":"2016","journal-title":"Autophagy"},{"issue":"7","key":"10.1016\/j.npep.2025.102583_bb0575","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1111\/jcmm.15016","article-title":"Treatment of diabetic retinopathy through neuropeptide Y-mediated enhancement of neurovascular microenvironment","volume":"24","author":"Ou","year":"2020","journal-title":"J. Cell. Mol. Med."},{"issue":"5","key":"10.1016\/j.npep.2025.102583_bb0580","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/fcp.12464","article-title":"Inflammatory process in Parkinson disease: neuroprotection by neuropeptide Y","volume":"33","author":"Pain","year":"2019","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"22","key":"10.1016\/j.npep.2025.102583_bb0585","doi-asserted-by":"crossref","DOI":"10.3390\/cells11223665","article-title":"Neuroprotective effects of neuropeptide Y on human neuroblastoma SH-SY5Y cells in glutamate excitotoxicity and ER stress conditions","volume":"11","author":"Palanivel","year":"2022","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.npep.2025.102583_bb0590","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/pnasnexus\/pgae299","article-title":"Neuropeptide Y receptor activation preserves inner retinal integrity through PI3K\/Akt signaling in a glaucoma mouse model","volume":"3","author":"Palanivel","year":"2024","journal-title":"PNAS Nexus"},{"key":"10.1016\/j.npep.2025.102583_bb0595","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fendo.2013.00005","article-title":"Neuropeptide Y receptors: how to get subtype selectivity","volume":"4","author":"Pedragosa-Badia","year":"2013","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"24","key":"10.1016\/j.npep.2025.102583_bb0600","doi-asserted-by":"crossref","DOI":"10.3390\/nu16244368","article-title":"Mechanisms and potential benefits of neuroprotective agents in neurological health","volume":"16","author":"Pekdemir","year":"2024","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.npep.2025.102583_bb0605","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2337\/diacare.27.2.503","article-title":"Leucine 7 to proline 7 polymorphism in the preproneuropeptide Y is associated with proteinuria, coronary heart disease, and glycemic control in type 1 diabetic patients","volume":"27","author":"Pettersson-Fernholm","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.npep.2025.102583_bb0610","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2018.00834","article-title":"The role of endogenous neuroprotective mechanisms in the prevention of retinal ganglion cells degeneration","volume":"12","author":"Pietrucha-Dutczak","year":"2018","journal-title":"Front. Neurosci."},{"issue":"4","key":"10.1016\/j.npep.2025.102583_bb0615","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/09513590500519385","article-title":"Plasma levels of neuropeptides in Alzheimer\u2019s disease","volume":"22","author":"Proto","year":"2006","journal-title":"Gynecol. Endocrinol."},{"issue":"21","key":"10.1016\/j.npep.2025.102583_bb0620","doi-asserted-by":"crossref","first-page":"8169","DOI":"10.1523\/JNEUROSCI.17-21-08169.1997","article-title":"Inhibition of synaptic transmission by neuropeptide Y in rat hippocampal area CA1: modulation of presynaptic Ca2+ entry","volume":"17","author":"Qian","year":"1997","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.npep.2025.102583_bb0625","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s12640-019-0003-y","article-title":"The role of PI3K\/Akt and ERK in neurodegenerative disorders","volume":"35","author":"Rai","year":"2019","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.npep.2025.102583_bb0630","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.npep.2015.09.008","article-title":"Neuropeptide Y: A stressful review","volume":"55","author":"Reichmann","year":"2016","journal-title":"Neuropeptides"},{"issue":"5","key":"10.1016\/j.npep.2025.102583_bb0635","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.160","article-title":"Neuropeptide Y receptors activation protects rat retinal neural cells against necrotic and apoptotic cell death induced by glutamate","volume":"4","author":"Santos-Carvalho","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.npep.2025.102583_bb0640","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.pneurobio.2013.10.002","article-title":"Emerging novel roles of neuropeptide Y in the retina: from neuromodulation to neuroprotection","volume":"112","author":"Santos-Carvalho","year":"2014","journal-title":"Prog. Neurobiol."},{"issue":"1","key":"10.1016\/j.npep.2025.102583_bb0645","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1507\/endocrj.46.139","article-title":"Elevated plasma immunoreactive neuropeptide Y concentrations and its increased urinary excretion in patients with advanced diabetic nephropathy","volume":"46","author":"Satoh","year":"1999","journal-title":"Endocr. J."},{"issue":"2","key":"10.1016\/j.npep.2025.102583_bb0650","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.peptides.2012.07.024","article-title":"Secretoneurin, substance P and neuropeptide Y in the oxygen-induced retinopathy in C57Bl\/6N mice","volume":"37","author":"Schmid","year":"2012","journal-title":"Peptides"},{"issue":"6","key":"10.1016\/j.npep.2025.102583_bb0655","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.3390\/neurolint16060100","article-title":"The role of neuropeptide Y in the pathogenesis of Alzheimer's disease: diagnostic significance and neuroprotective functions","volume":"16","author":"Shapovalova","year":"2024","journal-title":"Neurol. Int."},{"issue":"3","key":"10.1016\/j.npep.2025.102583_bb0660","article-title":"Modern methods of diagnostics and treatment of neurodegenerative diseases and depression","volume":"13","author":"Shusharina","year":"2023","journal-title":"Diagnostics (Basel)"},{"issue":"9","key":"10.1016\/j.npep.2025.102583_bb0665","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1096\/fj.02-0885fje","article-title":"Activation of neuropeptide Y receptors is neuroprotective against excitotoxicity in organotypic hippocampal slice cultures","volume":"17","author":"Silva","year":"2003","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.npep.2025.102583_bb0670","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.npep.2009.02.002","article-title":"Neuroprotective effects of neuropeptide Y-Y2 and Y5 receptor agonists in vitro and in vivo","volume":"43","author":"Smialowska","year":"2009","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2025.102583_bb0675","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109201","article-title":"Neuropeptide Y modulates excitatory synaptic transmission and promotes social behavior in the mouse nucleus accumbens","volume":"217","author":"Smith","year":"2022","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.npep.2025.102583_bb0680","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/glia.10107","article-title":"Y1 receptor of neuropeptide Y as a glial marker in proliferative vitreoretinopathy and diseased human retina","volume":"39","author":"Soler","year":"2002","journal-title":"Glia"},{"issue":"2","key":"10.1016\/j.npep.2025.102583_bb0685","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11020446","article-title":"The bidirectional relationship of NPY and mitochondria in energy balance regulation","volume":"11","author":"Sousa","year":"2023","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.npep.2025.102583_bb0690","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0014-4886(91)90080-V","article-title":"Decreased levels of [met]enkephalin, neuropeptide Y, substance P, and vasoactive intestinal peptide in parkinsonian adrenal medulla","volume":"114","author":"Stoddard","year":"1991","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.npep.2025.102583_bb0695","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13024-020-00397-1","article-title":"The role of TDP-43 mislocalization in amyotrophic lateral sclerosis","volume":"15","author":"Suk","year":"2020","journal-title":"Mol. Neurodegener."},{"issue":"Pt 1","key":"10.1016\/j.npep.2025.102583_bb0700","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1469-7793.2001.0067j.x","article-title":"Neuropeptide Y receptors differentially modulate G-protein-activated inwardly rectifying K+ channels and high-voltage-activated Ca2+ channels in rat thalamic neurons","volume":"531","author":"Sun","year":"2001","journal-title":"J. Physiol."},{"key":"10.1016\/j.npep.2025.102583_bb0705","first-page":"102","article-title":"Neuropeptide Y and calcitonin gene-related peptide in cerebrospinal fluid in Parkinson's disease with comorbid depression versus patients with major depressive disorder","volume":"8","author":"Svenningsson","year":"2017","journal-title":"Front. Psychol."},{"issue":"10","key":"10.1016\/j.npep.2025.102583_bb0710","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41582-020-0389-4","article-title":"Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities","volume":"16","author":"Tabrizi","year":"2020","journal-title":"Nat. Rev. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.npep.2025.102583_bb0715","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0169-328X(95)00299-8","article-title":"BDNF increases the expression of neuropeptide Y mRNA and promotes differentiation\/maturation of neuropeptide Y-positive cultured cortical neurons from embryonic and postnatal rats","volume":"37","author":"Takei","year":"1996","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.npep.2025.102583_bb0720","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.3389\/fphys.2018.01281","article-title":"The role of neuropeptide Y in cardiovascular health and disease","volume":"9","author":"Tan","year":"2018","journal-title":"Front. Physiol."},{"issue":"18","key":"10.1016\/j.npep.2025.102583_bb0725","doi-asserted-by":"crossref","first-page":"5485","DOI":"10.1073\/pnas.79.18.5485","article-title":"Neuropeptide Y: complete amino acid sequence of the brain peptide","volume":"79","author":"Tatemoto","year":"1982","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5764","key":"10.1016\/j.npep.2025.102583_bb0730","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/285417a0","article-title":"Isolation of two novel candidate hormones using a chemical method for finding naturally occurring polypeptides","volume":"285","author":"Tatemoto","year":"1980","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.npep.2025.102583_bb0735","article-title":"Adult neurogenesis in the mammalian central nervous system: functionality and potential clinical interest","volume":"11","author":"Taupin","year":"2005","journal-title":"Med. Sci. Monit."},{"issue":"10","key":"10.1016\/j.npep.2025.102583_bb0740","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8101659","article-title":"Antioxidant therapies for neuroprotection-a review","volume":"8","author":"Teleanu","year":"2019","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.npep.2025.102583_bb0745","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1021\/acs.analchem.9b03505","article-title":"Quantification of neuropeptide Y and four of its metabolites in human plasma by Micro-UHPLC-MS\/MS","volume":"92","author":"Vocat","year":"2020","journal-title":"Anal. Chem."},{"issue":"5","key":"10.1016\/j.npep.2025.102583_bb0750","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/jnc.13624","article-title":"Neuropeptide Y (NPY) in cerebrospinal fluid from patients with Huntington\u2019s disease: increased NPY levels and differential degradation of the NPY1-30 fragment","volume":"137","author":"Wagner","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.npep.2025.102583_bb0755","doi-asserted-by":"crossref","first-page":"7898095","DOI":"10.1155\/2019\/7898095","article-title":"NPY receptor 2 mediates NPY antidepressant effect in the mPFC of LPS rat by suppressing NLRP3 signaling pathway","volume":"2019","author":"Wang","year":"2019","journal-title":"Mediat. Inflamm."},{"issue":"1","key":"10.1016\/j.npep.2025.102583_bb0760","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13024-022-00524-0","article-title":"Solving neurodegeneration: common mechanisms and strategies for new treatments","volume":"17","author":"Wareham","year":"2022","journal-title":"Mol. Neurodegener."},{"issue":"6","key":"10.1016\/j.npep.2025.102583_bb0765","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1152\/jn.1990.63.6.1499","article-title":"Neuropeptide Y reduces calcium current and inhibits acetylcholine release in nodose neurons via a pertussis toxin-sensitive mechanism","volume":"63","author":"Wiley","year":"1990","journal-title":"J. Neurophysiol."},{"issue":"4","key":"10.1016\/j.npep.2025.102583_bb0770","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","article-title":"Hallmarks of neurodegenerative diseases","volume":"186","author":"Wilson","year":"2023","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.npep.2025.102583_bb0775","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1745-7254.2005.00011.x","article-title":"Neuropeptide Y expression in mouse hippocampus and its role in neuronal excitotoxicity","volume":"26","author":"Wu","year":"2005","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.npep.2025.102583_bb0780","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1073\/pnas.96.1.254","article-title":"Neuroprotection with noninvasive neurotrophin delivery to the brain","volume":"96","author":"Wu","year":"1999","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"8","key":"10.1016\/j.npep.2025.102583_bb0785","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1111\/j.1460-9568.2008.06172.x","article-title":"Interaction between neuropeptide Y (NPY) and brain-derived neurotrophic factor in NPY-mediated neuroprotection against excitotoxicity: a role for microglia","volume":"27","author":"Xapelli","year":"2008","journal-title":"Eur. J. Neurosci."},{"issue":"3","key":"10.1016\/j.npep.2025.102583_bb0790","first-page":"346","article-title":"Measurement of lumbar CSF levels of met-enkephalin, encrypted met-enkephalin, and neuropeptide Y in normal patients and in patients with Parkinson\u2019s disease before and after autologous transplantation of adrenal medulla into the caudate nucleus","volume":"115","author":"Yaksh","year":"1990","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.npep.2025.102583_bb0795","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.brainres.2012.09.013","article-title":"Modulation of methamphetamine-induced nitric oxide production by neuropeptide Y in the murine striatum","volume":"1483","author":"Yarosh","year":"2012","journal-title":"Brain Res."},{"issue":"6","key":"10.1016\/j.npep.2025.102583_bb0800","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1046\/j.1442-9071.2002.00573.x","article-title":"Neuropeptide Y expression in a mouse model of oxygen-induced retinopathy","volume":"30","author":"Yoon","year":"2002","journal-title":"Clin. Experiment. Ophthalmol."},{"issue":"1","key":"10.1016\/j.npep.2025.102583_bb0805","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s13578-021-00657-7","article-title":"Regulation of neuropeptide Y in body microenvironments and its potential application in therapies: a review","volume":"11","author":"Zhang","year":"2021","journal-title":"Cell Biosci."},{"issue":"3","key":"10.1016\/j.npep.2025.102583_bb0810","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12264-008-0130-6","article-title":"Neuropeptide Y promotes TGF-beta1 production in RAW264.7 cells by activating PI3K pathway via Y1 receptor","volume":"24","author":"Zhou","year":"2008","journal-title":"Neurosci. Bull."}],"container-title":["Neuropeptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417925000836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417925000836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T14:22:51Z","timestamp":1770387771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143417925000836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":162,"alternative-id":["S0143417925000836"],"URL":"https:\/\/doi.org\/10.1016\/j.npep.2025.102583","relation":{},"ISSN":["0143-4179"],"issn-type":[{"value":"0143-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuropeptide Y at the crossroads of neurodegeneration: Mechanistic insights and emerging therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"Neuropeptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.npep.2025.102583","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102583"}}